Cabozantinib and IL-27 combinatorial therapy for bone-metastatic prostate cancer

Overview of attention for article published in Frontiers in Molecular Biosciences, September 2023

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 X post from an account with 2,518 followers.

New Research: Cabozantinib and IL-27 combinatorial therapy for bone-metastatic prostate cancer #MolBioSci https://t.co/1hlrm5Me9F

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.